GSK-114479

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase II Study to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Once-Daily Dosing of the Oral Motilin Receptor Agonist GSK962040, in Type I and II Diabetic Male and Female Subjects with Gastroparesis

Medicine or Vaccine (generic name)

camicinal

Sponsor Identification Number

114479

Trial Registry Identification Number(#'s)

NCT01262898

Medical Condition

Gastroparesis

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=114479

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01262898

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2010-023186-21

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2021